2002
DOI: 10.1006/bbrc.2001.6136
|View full text |Cite
|
Sign up to set email alerts
|

Side Chain Modifications Change the Binding and Agonist Properties of Endomorphin 2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
38
0

Year Published

2007
2007
2014
2014

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 38 publications
(39 citation statements)
references
References 38 publications
1
38
0
Order By: Relevance
“…The concentration of test compound at the beginning of the experiment was 100 μM, and the assay was performed at 37° C shaking at 400 rpm. Samples (10 μL) were taken at selected time points (5,10,15,20,30,40,50,60 and 120 minutes) and immediately added to 5 μL of TFA to stop digestion and then diluted with 85 μL of water/DMSO solution so that there was a final concentration of 10% by volume of DMSO. This addition of DMSO was shown to improve the resolution and reproducibility of the LC/MS analysis, particularly of the lipophilic peptides.…”
Section: Cell Culturementioning
confidence: 99%
See 1 more Smart Citation
“…The concentration of test compound at the beginning of the experiment was 100 μM, and the assay was performed at 37° C shaking at 400 rpm. Samples (10 μL) were taken at selected time points (5,10,15,20,30,40,50,60 and 120 minutes) and immediately added to 5 μL of TFA to stop digestion and then diluted with 85 μL of water/DMSO solution so that there was a final concentration of 10% by volume of DMSO. This addition of DMSO was shown to improve the resolution and reproducibility of the LC/MS analysis, particularly of the lipophilic peptides.…”
Section: Cell Culturementioning
confidence: 99%
“…In this study we have chemically modified the termini of endomorphin 1 to investigate systematically how these changes can affect stability, permeability and biological activity. Structure activity studies on the endomorphins have revealed the importance of the Tyr 1 and Trp 3 residues to receptor binding 15,16 and Pro 2 to the correct structural orientation of the peptide. 17, 18 Our modifications, therefore, concentrated on the addition of lipidic and/or carbohydrate units to either termini while maintaining the native peptide sequence.…”
Section: Introductionmentioning
confidence: 99%
“…EM1 and EM2 were also characterized for comparison, and the affinity values are in agreement with those published previously (K i (m) = 4.55 and 8.23 nm, respectively). [17,25] The opioid receptor binding properties of the new EM analogues are summarized in (7), which is the most potent EM1 analogue, increased about twofold (K i (m) = 2.32 nm), and d affinity increased 1.6-fold over its parent, consequently giving a slight increase in m selectivity (K i (d)/K i (m) = 1417). Although both m and d affinity of the most potent EM2 derivative 21 increased in binding assays, the selectivity decreased about threefold (K i (d)/K i (m) = 676) relative to that of EM2.…”
Section: Opioid Receptor Affinity and Selectivitymentioning
confidence: 99%
“…It further demonstrates that the distance between the C-terminal aromatic ring and peptide backbone has a strong effect on MOR binding. [25] EM1 and EM2 only differ in one amino acid. The side chain of Trp 3 of EM1 is an indole ring, which is a relatively bulky group compared with Phe 3 of EM2.…”
Section: Solution Conformation Analysismentioning
confidence: 99%
See 1 more Smart Citation